ArticleInvestigative ophthalmology & visual science2026
"Time to See" in Infantile Nystagmus.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Interventions that dampen the involuntary eye oscillation in infantile nystagmus (IN) often only elicit modest improvement in visual acuity (VA), even when subjective improvement is reported. Unique to nystagmus, the repeated movement of the fovea away from the intended visual target introduces a temporal dimension to vision. We hypothesized that the viewing time required to resolve optotype stimuli is increased in people with IN and that this measure of "time to see" increases with IN severity. Methods: Exposure duration thresholds (viewing times) were measured psychophysically for 18 individuals with IN and 14 controls for an optotype orientation discrimination task at spatial frequencies varying relative to each participant's VA. Viewing times were measured at two gaze positions (toward the IN null zone, where waveform intensity is lower, and away from the null zone, where intensity is higher) to establish the effect of IN severity as quantified by intensity. Results: Exposure duration thresholds were significantly longer in those with IN than controls (P = 0.027) and increased significantly with IN intensity (P = 0.034). Both effects were greatest for optotypes sized at participant-relative VA. Conclusions: "Time to See" is increased in IN and is sensitive to within-participant changes in IN severity, suggesting that exposure duration threshold could be a useful measure of visual function in people with IN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.